Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

19. September 2023 11:59 ET | Quelle: King Dental: David King, DMD

Top Dentist in Huntsville David King, DMD Expands Dental Services

Huntsville, AL, Sept. 19, 2023 (GLOBE NEWSWIRE) -- David King, a top dentist in Huntsville, is pleased to share that his dental office has expanded its dental services. King Dental now offers...
14. August 2018 16:05 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma Announces Second Quarter 2018 Operating Results and Provides Corporate Update

SAN DIEGO , Aug. 14, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel...
08. August 2018 16:05 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma to Host Conference Call and Webcast of Second Quarter 2018 Financial Results on August 14, 2018

SAN DIEGO, Aug. 08, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
26. Juli 2018 08:00 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma Presents Positive Lung and Skin Findings with ATYR1923 in a Translational Animal Model at the Scleroderma Foundation National Patient Education Conference

SAN DIEGO, July 26, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
08. Mai 2018 08:00 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma to Host Conference Call and Webcast of First Quarter 2018 Financial Results on May 14, 2018

SAN DIEGO, May 08, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
02. Mai 2018 08:00 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma Provides Mechanistic Update on Resokine Pathway at American Academy of Immunology Annual Meeting

SAN DIEGO, May 02, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
19. März 2018 16:05 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma Announces Fourth Quarter and Year-End 2017 Operating Results and Provides Corporate Update

SAN DIEGO, March 19, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...